| Autor: |
Chang CV; Department of Medicine, Faculdade de Medicina de Botucatu, Universidade Estadual de São Paulo, Botucatu, SP, Brazil. chang.cv@gmail.com, Conde SJ, Luvizotto RA, Nunes VS, Bonates MC, Felicio AC, Lindsey SC, Moraes FH, Tagliarini JV, Mazeto GM, Kopp P, Nogueira CR |
| Jazyk: |
angličtina |
| Zdroj: |
Arquivos brasileiros de endocrinologia e metabologia [Arq Bras Endocrinol Metabol] 2012 Nov; Vol. 56 (8), pp. 570-3. |
| DOI: |
10.1590/s0004-27302012000800018 |
| Abstrakt: |
Diagnosing oncogenic osteomalacia is still a challenge. The disorder is characterized by osteomalacia caused by renal phosphate wasting and low serum concentration of 1,25-dihydroxyvitamin D3 occurring in the presence of a tumor that produces high levels of fibroblast growth factor 23. However, it is possible that the disease is much more misdiagnosed than rare. We present the case of a 42-year-old man with a long-term history of undiagnosed progressive muscle weakness. His laboratory results mainly showed low serum phosphate. Surgical removal of a nasal hemangiopericytoma that had been diagnosed five years earlier, brought him to a symptom-free condition. Even though knowing the underlying etiology would explain his osteomalacia, the patient sought medical help from countless physicians for five consecutive years, and only after adequate treatment a rewarding outcome was achieved. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
